X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PIRAMAL ENTERPRISES - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PIRAMAL ENTERPRISES J.B.CHEMICALS/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 15.9 39.0 40.8% View Chart
P/BV x 2.5 3.2 77.6% View Chart
Dividend Yield % 0.2 0.8 20.5%  

Financials

 J.B.CHEMICALS   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
PIRAMAL ENTERPRISES
Mar-17
J.B.CHEMICALS/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3182,095 15.2%   
Low Rs2001,025 19.5%   
Sales per share (Unadj.) Rs148.0492.8 30.0%  
Earnings per share (Unadj.) Rs19.172.6 26.3%  
Cash flow per share (Unadj.) Rs23.994.7 25.3%  
Dividends per share (Unadj.) Rs0.5021.00 2.4%  
Dividend yield (eoy) %0.21.3 14.4%  
Book value per share (Unadj.) Rs128.9862.5 15.0%  
Shares outstanding (eoy) m84.82172.56 49.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.2 55.2%   
Avg P/E ratio x13.621.5 63.1%  
P/CF ratio (eoy) x10.816.5 65.6%  
Price / Book Value ratio x2.01.8 111.0%  
Dividend payout %2.628.9 9.1%   
Avg Mkt Cap Rs m21,951269,194 8.2%   
No. of employees `0002.74.0 68.1%   
Total wages/salary Rs m1,84117,939 10.3%   
Avg. sales/employee Rs Th4,590.921,190.3 21.7%   
Avg. wages/employee Rs Th673.44,470.1 15.1%   
Avg. net profit/employee Rs Th592.13,120.0 19.0%   
INCOME DATA
Net Sales Rs m12,55185,037 14.8%  
Other income Rs m5422,338 23.2%   
Total revenues Rs m13,09387,374 15.0%   
Gross profit Rs m2,05534,991 5.9%  
Depreciation Rs m4123,817 10.8%   
Interest Rs m9620,310 0.5%   
Profit before tax Rs m2,08813,202 15.8%   
Minority Interest Rs m01,699 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-100 0.0%   
Tax Rs m4692,281 20.6%   
Profit after tax Rs m1,61912,520 12.9%  
Gross profit margin %16.441.1 39.8%  
Effective tax rate %22.517.3 130.0%   
Net profit margin %12.914.7 87.6%  
BALANCE SHEET DATA
Current assets Rs m7,77887,590 8.9%   
Current liabilities Rs m4,358185,578 2.3%   
Net working cap to sales %27.2-115.2 -23.6%  
Current ratio x1.80.5 378.1%  
Inventory Days Days5531 176.1%  
Debtors Days Days8048 168.3%  
Net fixed assets Rs m5,713108,523 5.3%   
Share capital Rs m170345 49.1%   
"Free" reserves Rs m10,547148,481 7.1%   
Net worth Rs m10,937148,826 7.3%   
Long term debt Rs m0144,957 0.0%   
Total assets Rs m15,574482,394 3.2%  
Interest coverage x22.81.7 1,383.0%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.80.2 457.2%   
Return on assets %11.06.8 161.7%  
Return on equity %14.88.4 175.9%  
Return on capital %20.012.0 167.0%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889NA-   
Fx inflow Rs m6,16915,001 41.1%   
Fx outflow Rs m1,2855,150 25.0%   
Net fx Rs m4,8849,851 49.6%   
CASH FLOW
From Operations Rs m1,397-100,393 -1.4%  
From Investments Rs m-320-24,202 1.3%  
From Financial Activity Rs m-1,196135,705 -0.9%  
Net Cashflow Rs m-10211,110 -0.9%  

Share Holding

Indian Promoters % 55.4 52.9 104.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 4.0 84.8%  
FIIs % 3.9 26.6 14.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 16.5 224.2%  
Shareholders   30,437 93,274 32.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT LTD.  SUN PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jan 19, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - DISHMAN PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS